Skip to main content
Theratechnologies Inc. (THTX)
NASDAQ: THTX · Real-Time Price · USD
1.440
+0.010 (0.70%)
Jan 31, 2025, 4:00 PM EST - Market closed

Theratechnologies Revenue

Theratechnologies had revenue of $22.60M in the quarter ending August 31, 2024, with 8.37% growth. This brings the company's revenue in the last twelve months to $84.32M, up 5.75% year-over-year. In the fiscal year ending November 30, 2023, Theratechnologies had annual revenue of $81.76M with 2.13% growth.

Revenue (ttm)
$84.32M
Revenue Growth
+5.75%
P/S Ratio
n/a
Revenue / Employee
$818,602
Employees
103
Market Cap
67.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Nov 30, 202381.76M1.71M2.13%
Nov 30, 202280.06M10.23M14.66%
Nov 30, 202169.82M3.77M5.71%
Nov 30, 202066.05M2.84M4.49%
Nov 30, 201963.22M18.00M39.81%
Nov 30, 2018 Pro Pro Pro
Nov 30, 2017 Pro Pro Pro
Nov 30, 2016 Pro Pro Pro
Nov 30, 2015 Pro Pro Pro
Nov 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 63.17B
AbbVie 56.33B
Novartis AG 51.72B
AstraZeneca 51.21B
Thermo Fisher Scientific 42.88B
Abbott Laboratories 41.95B
Revenue Rankings

THTX News

More News